SLG
BDSI

Stanley-Laman Group’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Stanley-Laman Group’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-416,722
Closed -$1.5M – 308
2021
Q3 		$1.5M Buy
416,722
+37,120
+10% +$140K 0.2% 158
2021
Q2 		$1.36M Buy
379,602
+30,137
+9% +$106K 0.19% 160
2021
Q1 		$1.37M Buy
+349,465
New +$1.44M 0.23% 146

Other funds holding BDSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stanley-Laman Group's BDSI Position: Q4 2021 in Review

Stanley-Laman Group sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2021, closing a stake of 416,722 shares — an estimated $1.5M sold.

Stanley-Laman Group first reported a position in BDSI in Q1 2021 and held it in 3 quarters. The position peaked at $1.5M in Q3 2021. 156 funds tracked by Wall St. Rank hold BDSI as of Q4 2021.

  • Stanley-Laman Group reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2021 after selling out during the quarter.
  • Stanley-Laman Group sold 416,722 BioDelivery Sciences International, Inc. shares in Q4 2021, an estimated $1.5M.
  • Stanley-Laman Group first reported a position in BioDelivery Sciences International, Inc. in Q1 2021 and held it in 3 quarters.
  • Stanley-Laman Group's BioDelivery Sciences International, Inc. position peaked at $1.5M in Q3 2021.
  • 156 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2021.

Based on Stanley-Laman Group's 13F filing for Q4 2021, filed 25 Jan 2022.